Latest Breaking News On - Michaelj farrell - Page 3 : comparemela.com

Michael J Farrell Sells 14,683 Shares of ResMed Inc (NYSE:RMD) Stock

Michael J Farrell Sells 14,683 Shares of ResMed Inc (NYSE:RMD) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United kingdomGreat lakesCanada generalMichaelj farrellBenjaminf edwards company incSecurities exchange commissionGreat lakes advisorsNeedham companyResmed incRoyal bankGulf international bank united kingdom ltdMv capital management incEnvestnet portfolio solutions incGet free reportExchange commissionPortfolio solutions

ResMed Inc (NYSE:RMD) CEO Sells $3,178,869 50 in Stock

ResMed Inc (NYSE:RMD) CEO Sells $3,178,869 50 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesMichaelj farrellBlair william coAsset management coNeedham companyResmed incDearborn partnersBoard of administration florida retirement systemMitsubishi ufjGet free reportFlorida retirement systemMed incRespiratory careResmed daily

ResMed : Q3 2024 ResMed Earnings Results Webcast Transcript

REFINITIV STREETEVENTS EDITED TRANSCRIPT RMD.N - Q3 2024 Resmed Inc Earnings Call EVENT.

United statesNew south walesSan diegoRed seaDjibouti generalBretta sandercockCraig wong panAmy wakehamBrett fishbinLyanne harrison bofMike toomey jefferiesMick farrellGoogle fitbitDan hurrenLaura sutcliffeMichaelj farrell

UBS Group AG Buys 239,001 Shares of ResMed Inc (NYSE:RMD)

UBS Group AG Buys 239,001 Shares of ResMed Inc (NYSE:RMD)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Michaelj farrellBrett sandercockUbs groupNorges bankCapital research global investorsRoyal bankRenaissance technologiesResmed incJpmorgan chase coExchange commissionBarclays plcFree reportResearch global investorsGet free reportMed incRespiratory care

ResMed (RMD) – Investment Analysts Recent Ratings Updates

ResMed (NYSE: RMD) recently received a number of ratings updates from brokerages and research firms: 2/6/2024 – ResMed is now covered by analysts at KeyCorp. They set an “overweight” rating and a $227.00 price target on the stock. 1/30/2024 – ResMed had its price target raised by analysts at Oppenheimer Holdings Inc. from $185.00 to […]

Michaelj farrellBrett sandercockNews ratings for resmed inc dailyRoyal bankAscent groupJpmorgan chase coCapital impact advisorsSeacrest wealth managementOppenheimer holdings incCigna investments incNeedham companySecurities exchange commissionResmed incOppenheimer holdingsGet free reportExchange commission